Seth Toback, MD, MMM

We're back! Well, in a virtual sort of way. We are happy to start providing interesting and topical speakers again, safely and socially distant. Join us as we once again bring you thought provoking and relevant experts, specialists, pundits, and others to spark reflection and discussion.

What would be more relevant and topical to start this all off again than an expert on vaccine development?

Dr. Seth Toback is currently a Vice President of Clinical Development at Novavax. He is working on the clinical development of the SARS CoV-2 vaccine and is the lead physician on the phase 3 study being conducted in the United Kingdom.

Dr. Toback has worked in the pharmaceutical and biotechnology fields for the past 12 years focusing on vaccines and therapeutics against respiratory viruses. Prior to that he was in private practice pediatrics in Pittsburgh Pennsylvania close to where he trained at the Children’s Hospital of Pittsburgh. He is a board-certified Pediatrician with degrees from Carnegie-Mellon, Heinz School of Public Policy and Management, Tufts University School of Medicine and McGill University.